- Home
- XNCR vs FDUS Comparison
XNCR vs FDUS Comparison
Compare XNCR & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- FDUS
- Stock Information
- Founded
- XNCR 1997
- FDUS 2011
- Country
- XNCR United States
- FDUS United States
- Employees
- XNCR N/A
- FDUS N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- FDUS Finance/Investors Services
- Sector
- XNCR Health Care
- FDUS Finance
- Exchange
- XNCR Nasdaq
- FDUS Nasdaq
- Market Cap
- XNCR 568.3M
- FDUS 654.0M
- IPO Year
- XNCR 2013
- FDUS 2011
- Fundamental
- Price
- XNCR $8.20
- FDUS $20.08
- Analyst Decision
- XNCR Buy
- FDUS Hold
- Analyst Count
- XNCR 9
- FDUS 1
- Target Price
- XNCR $30.13
- FDUS $20.00
- AVG Volume (30 Days)
- XNCR 970.6K
- FDUS 148.7K
- Earning Date
- XNCR 05-07-2025
- FDUS 05-08-2025
- Dividend Yield
- XNCR N/A
- FDUS 11.26%
- EPS Growth
- XNCR N/A
- FDUS N/A
- EPS
- XNCR N/A
- FDUS 2.33
- Revenue
- XNCR $127,228,000.00
- FDUS $147,999,000.00
- Revenue This Year
- XNCR N/A
- FDUS $2.37
- Revenue Next Year
- XNCR $25.05
- FDUS $7.45
- P/E Ratio
- XNCR N/A
- FDUS $8.62
- Revenue Growth
- XNCR N/A
- FDUS 9.06
- 52 Week Low
- XNCR $7.16
- FDUS $16.70
- 52 Week High
- XNCR $27.24
- FDUS $23.55
- Technical
- Relative Strength Index (RSI)
- XNCR 37.73
- FDUS 59.68
- Support Level
- XNCR $7.89
- FDUS $18.71
- Resistance Level
- XNCR $9.37
- FDUS $20.43
- Average True Range (ATR)
- XNCR 0.83
- FDUS 0.36
- MACD
- XNCR -0.13
- FDUS 0.22
- Stochastic Oscillator
- XNCR 9.09
- FDUS 82.09
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.